​

MetLife (MET) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MET Stock Forecast

MetLife (MET) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $93.50, with a high of $98.00 and a low of $84.00. This represents a 18.84% increase from the last price of $78.68.

$65 $72 $79 $86 $93 $100 High: $98 Avg: $93.5 Low: $84 Last Closed Price: $78.68

MET Stock Rating

MetLife stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (78.12%), 7 Hold (21.88%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 32 0 7 25 Strong Sell Sell Hold Buy Strong Buy

MET Price Target Upside V Benchmarks

TypeNameUpside
StockMetLife18.84%
SectorFinancial Services Stocks 6.68%
IndustryLife Insurance Stocks 15.22%

Price Target Trends

1M3M12M
# Anlaysts247
Avg Price Target$97.50$93.50$96.43
Last Closing Price$78.68$78.68$78.68
Upside/Downside23.92%18.84%22.56%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25484-117
Sep, 25573-116
Aug, 25574--16
Jul, 25574--16
Jun, 25574--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2025Barclays$98.00$82.7518.43%24.56%
Oct 07, 2025Bob HuangMorgan Stanley$97.00$82.7017.29%23.28%
Sep 19, 2025John BarnidgePiper Sandler$84.00$79.076.23%6.76%
Sep 15, 2025Tracy BenguiguiWolfe Research$95.00$80.4618.07%20.74%
Jul 14, 2025Bob HuangMorgan Stanley$98.00$77.7526.05%24.56%
Apr 02, 2025John BarnidgePiper Sandler$94.00$82.4913.95%19.47%
Feb 28, 2025Morgan Stanley$109.00$86.1826.48%38.54%
Oct 02, 2024John BarnidgePiper Sandler$92.00$81.7812.50%16.93%
Sep 04, 2024Alex ScottBarclays$91.00$77.5217.39%15.66%
Aug 01, 2024Joshua ShankerBank of America Securities$96.00$76.8524.92%22.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 08, 2025BarclaysOverweightOverweighthold
Oct 07, 2025Morgan StanleyOverweightOverweighthold
Sep 15, 2025Wolfe ResearchOutperformOutperforminitialise
Aug 22, 2025Cowen & Co.BuyBuyhold
Jul 14, 2025Morgan StanleyOverweightOverweighthold
Jul 10, 2025Wells FargoOverweightOverweighthold
May 06, 2025Wells FargoOverweightOverweighthold
Apr 02, 2025Piper SandlerOverweightOverweighthold
Mar 07, 2025Cowen & Co.BuyBuyhold
Jan 22, 2025BMO CapitalMarket Performinitialise

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.72$7.36$2.93$1.81$6.33---
Avg Forecast$5.68$8.47$6.95$7.31$8.21$9.61$10.74$11.96
High Forecast$5.92$8.83$7.23$7.44$8.33$9.86$11.56$13.81
Low Forecast$5.45$8.14$6.70$7.11$8.02$9.36$8.49$8.58
Surprise %0.70%-13.11%-57.84%-75.24%-22.90%---

Revenue Forecast

$60B $65B $70B $75B $80B $85B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$67.84B$71.08B$69.90B$66.41B$70.99B---
Avg Forecast$62.06B$67.68B$77.30B$71.42B$72.81B$76.54B$79.69B$83.81B
High Forecast$64.08B$69.88B$79.77B$72.37B$74.27B$79.27B$79.73B$83.81B
Low Forecast$60.18B$65.63B$75.22B$70.70B$71.50B$74.72B$79.64B$83.81B
Surprise %9.31%5.02%-9.58%-7.01%-2.51%---

Net Income Forecast

$1B $3B $5B $7B $9B $11B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B$6.86B$2.35B$1.58B$4.43B---
Avg Forecast$4.89B$3.87B$2.40B$1.38B$6.23B$7.33B$7.64B$6.60B
High Forecast$5.86B$4.64B$2.88B$1.66B$6.35B$7.52B$8.81B$10.52B
Low Forecast$3.91B$3.10B$1.92B$1.10B$6.12B$7.14B$6.47B$6.54B
Surprise %10.68%77.11%-1.76%14.35%-28.98%---

MET Forecast FAQ

Is MetLife stock a buy?

MetLife stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MetLife is a favorable investment for most analysts.

What is MetLife's price target?

MetLife's price target, set by 32 Wall Street analysts, averages $93.5 over the next 12 months. The price target range spans from $84 at the low end to $98 at the high end, suggesting a potential 18.84% change from the previous closing price of $78.68.

How does MetLife stock forecast compare to its benchmarks?

MetLife's stock forecast shows a 18.84% upside, outperforming the average forecast for the financial services stocks sector (6.68%) and outperforming the life insurance stocks industry (15.22%).

What is the breakdown of analyst ratings for MetLife over the past three months?

  • October 2025: 23.53% Strong Buy, 47.06% Buy, 23.53% Hold, 0% Sell, 5.88% Strong Sell.
  • September 2025: 31.25% Strong Buy, 43.75% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.
  • August 2025: 31.25% Strong Buy, 43.75% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is MetLife’s EPS forecast?

MetLife's average annual EPS forecast for its fiscal year ending in December 2025 is $9.61, marking a 51.82% increase from the reported $6.33 in 2024. Estimates for the following years are $10.74 in 2026, and $11.96 in 2027.

What is MetLife’s revenue forecast?

MetLife's average annual revenue forecast for its fiscal year ending in December 2025 is $76.54B, reflecting a 7.83% increase from the reported $70.99B in 2024. The forecast for 2026 is $79.69B, and $83.81B for 2027.

What is MetLife’s net income forecast?

MetLife's net income forecast for the fiscal year ending in December 2025 stands at $7.33B, representing an 65.58% increase from the reported $4.43B in 2024. Projections indicate $7.64B in 2026, and $6.6B in 2027.